17 January 2019 - Biopharmaceutical company Protagonist Therapeutics Inc (Nasdaq:PTGX) on Wednesday announced the grant of stock options to newly appointed executive vice president of clinical operations and pharmacology Suneel Gupta, PhD, in accorda...
17 January 2019 - Immuno-oncology company Targovax ASA (OSE:TRVX) revealed on Wednesday the receipt of the European patent that will protect its mutant-RAS specific neoantigen peptides, mutant RAS specific T cells and vaccines TG01 and TG02, for the ...
17 January 2019 - Biotechnology company Therachon AG said on Wednesday that it has passed the US Food and Drug Administration's (FDA) orphan drug designation for apraglutide for the treatment of short bowel syndrome (SBS).Short Bowel Syndrome (S...
17 January 2019 - Biotech company Bridge Biotherapeutics Inc revealed on Wednesday the receipt of the US Food and Drug Administration's (FDA) orphan drug designation (ODD) to promote the development of the drug candidate BBT-877 for the treatmen...
17 January 2019 - Biopharmaceutical company Acurx Pharmaceuticals LLC revealed on Wednesday the receipt of the US Food and Drug Administration's Fast Track designation to facilitate the development and expedite the regulatory pathway of the inve...